De gedichtjes hoeven niet te rijmen
Individualized Treatment : For patients with significant cardiovascular disease or heart failure, the decision to use Ozempic-like drugs must be individualized, weighing the benefits of glycemic control and weight loss against the potential risks, including muscle loss and any unknown cardiovascular effects
Your results can depend on several things, including your starting weight, health history, eating habits, activity level, dose, and how your body responds to the medication
discussion 503410
The regulatory pathway for new medications in Canada typically follows FDA approval in the United States by several months to over a year
The FDA prescribing information does not mandate tapering when discontinuing this dual GIP/GLP-1 receptor agonist